Stockreport

Insider Returns Down To US$166k As Tarsus Pharmaceuticals' Stock Dips 14% [Yahoo! Finance]

Tarsus Pharmaceuticals, Inc.  (TARS) 
PDF After accounting for the recent loss, the US$178.7k worth of shares they purchased is now worth US$345.1k, suggesting a good return on their investment. While we would [Read more]